Unituxin is a monoclonal antibody that targets the GD2 antigen present on neuroblastoma cells. Unituxin is one of the therapies used to treat children with high-risk neuroblastoma, a cancer that arises from immature nerve cells.
Link to animation:

Antibody -- style development


Neuroblastoma tumor cell and GD2 antigens -- style development





Immune cells and Neuroblastoma cells -- style development

Threatening cell -- targeted by the immune system

Antibody and GD2 Antigen interaction


Neuron and GD2 Antigen -- style development





